Aliment Pharmacol Ther

1. HALMOS EP, Gibson PR
   Editorial: Efficacy of Pharmacological Compared With Dietary Therapy for Patients With Irritable Bowel Syndrome-It Is Nice to Have a Choice.
   Aliment Pharmacol Ther. 2025 Nov 24. doi: 10.1111/apt.70452.
   

   >> Share

   
   
2. CHUAH KH, Loo QY, Loh AJC, Leong JY, et al
   Editorial: Efficacy of Pharmacological Compared With Dietary Therapy for Patients With Irritable Bowel Syndrome-It Is Nice to Have a Choice. Authors' Reply.
   Aliment Pharmacol Ther. 2025 Nov 24. doi: 10.1111/apt.70469.
   

   >> Share

   
   

   
   Bioengineering (Basel)

3. YERRAPRAGADA G, Lee J, Shariff MN, Elangovan P, et al
   A Novel Unsupervised You Only Listen Once (YOLO) Machine Learning Platform for Automatic Detection and Characterization of Prominent Bowel Sounds Towards Precision Medicine.
   Bioengineering (Basel). 2025;12:1271.
   

   >> Share

   
   

   
   Biol Sex Differ

4. BINOD M, Chang L, Hung MW, Dong TS, et al
   Multi-omics analysis reveal clinical-gut-brain interactions in female ibs patients with adverse childhood experiences.
   Biol Sex Differ. 2025;16:101.
   

   >> Share

   
   

   
   BMC Gastroenterol

5. YESHITILA ET, Aliye NJ, Mohammed Nur A, Yilma M, et al
   Prevalence and associated factors of irritable bowel syndrome among medical students in Ethiopia: a cross-sectional study.
   BMC Gastroenterol. 2025 Nov 26. doi: 10.1186/s12876-025-04415.
   

   >> Share

   
   

   
   BMC Public Health

6. BARBEK R, Makowski AC, von dem Knesebeck O
   Social inequalities, psychosocial influences, and symptom development in patients with irritable bowel syndrome - a longitudinal qualitative analysis of the SOMA.SOC study.
   BMC Public Health. 2025 Nov 26. doi: 10.1186/s12889-025-25628.
   

   >> Share

   
   

   
   Brain Sci

7. KESAVAN C, Strong DD, Strong RM
   Correction of Vitamin D Deficiency Improves PTSD Symptoms in Gulf War Veterans.
   Brain Sci. 2025;15:1135.
   

   >> Share

   
   

   
   Clin Biochem

8. MOU J, Tao Q, Xu L, Luo Y, et al
   Diagnostic accuracy of biomarkers for irritable bowel syndrome: a systematic review and meta-analysis.
   Clin Biochem. 2025;141:111061.
   

   >> Share

   
   

   
   Clin Gastroenterol Hepatol

9. PENNANEACH C, Bonham MP, Kelly T, Gibson R, et al
   High prevalence of disorders of irritable bowel syndrome and functional dyspepsia in night shift workers: a cross-sectional study in Australia and the UK.
   Clin Gastroenterol Hepatol. 2025 Nov 25:S1542-3565(25)01003.
   

   >> Share

   
   

   
   Endocr Metab Immune Disord Drug Targets

10. WU J, Liu Z, Liu L, Liu Q, et al
    Association Between Irritable Bowel Syndrome and Hypothyroidism: Insights from Large-Scale Population-Based Studies.
    Endocr Metab Immune Disord Drug Targets. 2025.
    

    >> Share

    
    

    
    Eur J Pediatr

11. DUBERG A, Eriksson M, Philipson A
    Parent-child agreement in reporting somatic distress, gastrointestinal symptoms, mental health, and general health in girls with functional abdominal pain.
    Eur J Pediatr. 2025;184:780.
    

    >> Share

    
    

    
    Front Immunol

12. LI X, Yuan Q, Huang H, Wang L, et al
    Gut microbiota in irritable bowel syndrome: a narrative review of mechanisms and microbiome-based therapies.
    Front Immunol. 2025;16:1695321.
    

    >> Share

    
    
13. KOTANI S, Mishima Y, Kishimoto K, Oka A, et al
    Association between Toll-like receptor 9 signaling defect and developing post-infectious irritable bowel syndrome.
    Front Immunol. 2025;16:1672117.
    

    >> Share

    
    
14. WANG Q, Meng Q, Chen Y, Liu Y, et al
    Interaction between gut microbiota and immunity in health and intestinal disease.
    Front Immunol. 2025;16:1673852.
    

    >> Share

    
    

    
    Front Microbiol

15. LONG Q, Li L, Tan Z, Deng N, et al
    Sishen Pill treats spleen-kidney yang deficiency IBS-D by influencing ATPase activity and intestinal microbiota.
    Front Microbiol. 2025;16:1610928.
    

    >> Share

    
    

    
    Gastroenterol Rep (Oxf)

16. DU L, Cheng F, Shen W, Zhu Y, et al
    Microbial dysbiosis-associated NMDAR hyperfunction in post-infectious irritable bowel syndrome with visceral hypersensitivity.
    Gastroenterol Rep (Oxf). 2025;13:goaf065.
    

    >> Share

    
    

    
    Gastroenterol Res Pract

17. JENSEN LG, Kjaer M, Andersen JR
    Modification of the Low FODMAP Diet Is Feasible in the Treatment of Irritable Bowel Syndrome: A Randomised Crossover Study.
    Gastroenterol Res Pract. 2025;2025:4152978.
    

    >> Share

    
    

    
    Headache

18. ZHAO SJ, Wang TT, Zhang Q, Akerman S, et al
    The role of stress in the comorbidity of migraine and other chronic primary pain.
    Headache. 2025 Nov 26. doi: 10.1111/head.70004.
    

    >> Share

    
    

    
    Int J Mol Sci

19. MAIMARIS S, Scarcella C, Memoli GA, Crisciotti C, et al
    Non-Coeliac Wheat Sensitivity: Symptoms in Search of a Mechanism, or a Distinct Well-Defined Clinical Entity? A Narrative Review.
    Int J Mol Sci. 2025;26:11174.
    

    >> Share

    
    

    
    J Affect Disord

20. JIA J, Wang M, Shi Y, Yang C, et al
    Sleep health as a mediator between depression and functional gastrointestinal disorders: A UK Biobank study.
    J Affect Disord. 2025 Nov 25:120768. doi: 10.1016/j.jad.2025.120768.
    

    >> Share

    
    

    
    J Clin Med

21. ARAI T, Hirose M, Kagawa T, Takeuchi N, et al
    Effectiveness of a 5-Hydroxytryptamine Type 3 Receptor Antagonist for Treating Nintedanib-Induced Diarrhea: A Prospective Observational Study.
    J Clin Med. 2025;14:7914.
    

    >> Share

    
    
22. GIGANTE G, Gostoli S, Dettori C, Montecchiarini M, et al
    Psychosomatic Profiles and Their Association with Health Behaviors in Patients with Inflammatory Bowel Disease (IBD) and Low Disease Activity.
    J Clin Med. 2025;14:7944.
    

    >> Share

    
    

    
    medRxiv

23. CHEN J, Li A, Wu W, Xu W, et al
    Machine learning to phenotype pain and predict response to pain interventions among young adults with irritable bowel syndrome.
    medRxiv [Preprint]. 2025 Oct 8:2025.10.07.25337516.
    

    >> Share

    
    

    
    Micromachines (Basel)

24. KARIMI FOROOD AM, Pandian SM, McNaboe RQ, De Carvalho Lachos T, et al
    Development and Validation of a Multimodal Wearable Belt for Abdominal Biosignal Monitoring with Application to Irritable Bowel Syndrome.
    Micromachines (Basel). 2025;16:1255.
    

    >> Share

    
    

    
    Nanomedicine

25. CAGIL EM, Yakhshilikova L, Ersoz M
    Smart bioconjugated MOFs for targeted drug delivery: Albumin and globulin effects on mebeverine release dynamics.
    Nanomedicine. 2025;71:102882.
    

    >> Share

    
    

    
    Nutrients

26. DALE HF, Kolby M, Valeur J
    Ultra-Processed Food Consumption and Irritable Bowel Syndrome: Current Evidence and Clinical Implications.
    Nutrients. 2025;17:3567.
    

    >> Share

    
    
27. AGGELETOPOULOU I, Karaivazoglou K, Kalafateli M, Triantos C, et al
    Targeting Irritable Bowel Syndrome Through Diet and Mechanism-Based Therapies: A Pathophysiological Approach.
    Nutrients. 2025;17:3595.
    

    >> Share

    
    

    
    Pain Rep

28. LIU Y, Li M, Lian X, Chen X, et al
    Mesenchymal stem cells' exosomes alleviate chronic visceral pain through Nrf-2-mediated oxidative stress pathway in rats.
    Pain Rep. 2025;10:e1372.
    

    >> Share

    
    

    
    Pathogens

29. RUDEN DM
    The Human Archaeome: Commensals, Opportunists, or Emerging Pathogens?
    Pathogens. 2025;14:1111.
    

    >> Share

    
    

    
    Phytomedicine

30. GUO X, Cheng T, Xuan M, Li G, et al
    Huoxiang Zhengqi oral liquid for irritable bowel syndrome with diarrhea: a multicenter, double-blind, randomized controlled trial.
    Phytomedicine. 2025;149:157567.
    

    >> Share

    
    

    
    Rev Med Virol

31. RETTURA F, Lambiase C, Bottari A, Filippini F, et al
    Gut Virome: What's the Role in Irritable Bowel Syndrome?
    Rev Med Virol. 2025;35:e70080.
    

    >> Share

    
    

    
    World J Gastroenterol

32. SUN YS, Bai XQ, Sun KD, Li J, et al
    Thymosin beta4 released by mast cells under stress conditions impairs intestinal epithelial barrier via IL22RA1/JAK1/STAT3 signaling in irritable bowel syndrome.
    World J Gastroenterol. 2025;31:111706.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share